MEF2C anticorps (pSer222)
Aperçu rapide pour MEF2C anticorps (pSer222) (ABIN6254109)
Antigène
Voir toutes MEF2C AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- pSer222
-
Réactivité croisée
- Humain
-
Homologie
- bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
-
Purification
- Antigen Affinity Purified from Pooled Serum
-
Immunogène
- Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- 100 μL in 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
-
Stock
- -20 °C
-
-
-
: "MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." dans: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
: "MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." dans: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
-
Autre désignation
- MEF2C
-
Poids moléculaire
- '51 kDa
-
ID gène
- 4208
-
UniProt
- Q06413
-
Pathways
- Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
Antigène
-